The global sleep apnea devices market size reached US$ 7.5 Billion in 2022. Looking forward, the analyst expects the market to reach US$ 11.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.
Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient’s respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global sleep apnea devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end-user.
Breakup by Product Type:
Positive Airway Pressure (PAP) Devices
Sleep Screening Devices
Breakup by End-User:
Hospitals and Clinics
Brealup by Region:
Middle East and Africa
United Arab Emirates
The competitive landscape of the industry has also been examined with some of the key players being BMC Medical Co., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Curative Medical, Devilbiss Healthcare, Fisher & Paykel Healthcare, GE Healthcare, Invacare, Oventus Medical, Panthera Dental, ResMed, Somnomed Ltd., Vyaire Medical Inc., Whole You Inc., etc.
Key Questions Answered in This Report:
What was the size of the global sleep apnea devices market in 2022?
What is the expected growth rate of the global sleep apnea devices market during 2023-2028?
What has been the impact of COVID-19 on the global sleep apnea devices market?
What are the key factors driving the global sleep apnea devices market?
What is the breakup of the global sleep apnea devices market based on the product type?
What is the breakup of the global sleep apnea devices market based on the end-user?
What are the key regions in the global sleep apnea devices market?
Who are the key players/companies in the global sleep apnea devices market?